Fallopian Tube Diseases - 25 Studies Found
Not yet recruiting |
: A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer :
|
Terminated |
: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer :
|
Active, not recruiting |
: Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer :
|
Recruiting |
: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies :
|
Completed |
: A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian : Primary Peritoneal Carcinoma : 2013-09-18 :
|